Pre-treatment inflammatory indexes as predictors of survival and cetuximab efficacy in metastatic colorectal cancer patients with wild-type RAS.
about
Pre-treatment inflammatory indexes as predictors of survival and cetuximab efficacy in metastatic colorectal cancer patients with wild-type RAS.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Pre-treatment inflammatory ind ...... r patients with wild-type RAS.
@en
Pre-treatment inflammatory ind ...... r patients with wild-type RAS.
@nl
type
label
Pre-treatment inflammatory ind ...... r patients with wild-type RAS.
@en
Pre-treatment inflammatory ind ...... r patients with wild-type RAS.
@nl
prefLabel
Pre-treatment inflammatory ind ...... r patients with wild-type RAS.
@en
Pre-treatment inflammatory ind ...... r patients with wild-type RAS.
@nl
P2093
P2860
P1433
P1476
Pre-treatment inflammatory ind ...... r patients with wild-type RAS.
@en
P2093
P2860
P2888
P356
10.1038/S41598-017-17130-6
P407
P577
2017-12-07T00:00:00Z
P6179
1093139733